GMT Capital’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-183,099
| Closed | -$9.05M | – | 101 |
|
|
2023
Q3 | $9.05M | Buy |
183,099
+4,661
| +3% | +$230K | 0.34% | 44 |
|
|
2023
Q2 | $14M | Buy |
178,438
+33,497
| +23% | +$2.62M | 0.53% | 33 |
|
|
2023
Q1 | $13.1M | Buy |
144,941
+24,991
| +21% | +$2.26M | 0.52% | 35 |
|
|
2022
Q4 | $14.2M | Hold |
119,950
| – | – | 0.65% | 37 |
|
|
2022
Q3 | $21.8M | Buy |
119,950
+37,725
| +46% | +$6.85M | 1.35% | 24 |
|
|
2022
Q2 | $7.38M | Buy |
82,225
+32,744
| +66% | +$2.94M | 0.47% | 41 |
|
|
2022
Q1 | $7.68M | Buy |
49,481
+20,274
| +69% | +$3.15M | 0.48% | 37 |
|
|
2021
Q4 | $8.69M | Buy |
29,207
+8,490
| +41% | +$2.53M | 0.67% | 28 |
|
|
2021
Q3 | $11.9M | Buy |
+20,717
| New | +$11.9M | 1.05% | 22 |
|